Evaluation of (89)Zr-pertuzumab in Breast Cancer Xenografts

[Image: see text] Pertuzumab is a monoclonal antibody that binds to HER2 and is used in combination with another HER2–specific monoclonal antibody, trastuzumab, for the treatment of HER2+ metastatic breast cancer. Pertuzumab binds to an HER2 binding site distinct from that of trastuzumab, and its af...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Mol Pharm
Asıl Yazarlar: Marquez, Bernadette V., Ikotun, Oluwatayo F., Zheleznyak, Alexander, Wright, Brian, Hari-Raj, Amrita, Pierce, Richard A., Lapi, Suzanne E.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: American Chemical Society 2014
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4224522/
https://ncbi.nlm.nih.gov/pubmed/25058168
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/mp500323d
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller